geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes


, : Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes. Biological Chemistry 388(2): 173-179

In this study, we tested the biological activity of a novel acylated form of (Pro(3))glucose-dependent insulinotropic polypetide [(Pro3)GIP] prepared by conjugating palmitic acid to Lys(16) to enhance its efficacy in vivo by promoting binding to albumin and extending its biological actions. Like the parent molecule (Pro(3))GIP, (Pro(3))GIPLys(16)PAL was completely stable to the actions of DPP-IV and significantly (p < 0.01 to p < 0.001) inhibited GIP-stimulated cAMP production and cellular insulin secretion. Furthermore, acute administration of (Pro(3))GIPLys(16)PAL also significantly (p < 0.05 to p < 0.001) countered the glucose-lowering and insulin-releasing actions of GIP in ob/ob mice. Daily injection of (Pro(3))GIPLys(16)PAL (25 nmol/kg bw) in 14-18-week-old ob/ob mice over 14 days had no effect on body weight, food intake or non-fasting plasma glucose and insulin concentrations. (Pro(3))GIPLys(16)PAL treatment also failed to significantly alter the glycaemic response to an i.p. glucose load or test meal, but insulin concentrations were significantly reduced (1.5-fold; p < 0.05) after the glucose load. Insulin sensitivity was enhanced (1.3-fold; p < 0.05) and pancreatic insulin was significantly reduced (p < 0.05) in the (Pro(3))GIPLys(16)PAL-treated mice. These data demonstrate that acylation of Lys(16) with palmitic acid in (Pro(3))GIP does not improve its biological effectiveness as a GIP receptor antagonist.

US$19.90

PMID: 17261080

DOI: 10.1515/BC.2007.019


Other references

Jackson, P., 1984: The use of SECAD suite of programs in the NHS. Hospital Engineering 38(12): 9-10

Lo; Petrasso; Wenzel, 1992: Comment on "Cluster-impact fusion". Physical Review Letters 68(13): 2107-2107

Henderson, D.; Dryer, S.E., 1992: Voltage- and Ca(2+)-activated ionic currents in acutely dissociated cells of the chick pineal gland. Previous research on cultured chick pineal cells suggests that melatonin production is modulated by Ca2+ influx through voltage-dependent Ca2+ channels. The possible existence of other ionic currents was investigated by means of whole-cell recordi...

Sankaranarayanan, R.; Duffy, S.W.; Padmakumary, G.; Nair, S.M.; Day, N.E.; Padmanabhan, T.K., 1991: Risk factors for cancer of the oesophagus in Kerala, India. A case-control study of oesophageal cancer was carried out in Trivandrum, Kerala, involving 267 cases and 895 controls. Risk factors studied in males were pan (betel)-tobacco chewing, bidi and cigarette smoking, drinking alcohol and taking snuff....

Bastin G.; Gevers M., 1978: Joint use of space interpolation and optimization methods for steady-state aquifer modeling with scarce data. Pages 427-441 1978

Shattuck, C.A.; Spellacy, W.N., 1965: Cirrhosis Of The Liver In Pregnancy. A Case Report And Review Of The Literature. Minnesota Medicine 48: 171-174

Lichtnecker, H.; Obeloer, M.; Schata, M., 1998: Illnesses from a hidden mold infestation. Zentralblatt fuer Hygiene und Umweltmedizin 201(1): 83-84, Feb

Mayer J.D., 1983: Estimating the sampling variance of correlation corrected for attenuation using coefficient alpha. A formula derived by Kelley estimates the sampling variance of the correlation corrected for attenuation by using split-half reliabilities. In some cases, the coefficient .alpha. estimate of reliability will be preferred for use over the split-hal...

Delâge, J.M., 1967: Immunology in the newborn. L'union Medicale du Canada 96(8): 970-974

Alexandre, C.; Baillard, Séphane.; Tavet, J.; Nüsse, O., 2016: The diffusional barrier, a new window for exclusion. Medecine Sciences 32(10): 827-830